Publications
- Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial2023 | First Faculty of Medicine
- Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey2023 | First Faculty of Medicine
- CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)2022 | First Faculty of Medicine, Faculty of Arts
- Challenges in lower limb lymphoedema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study2022 | First Faculty of Medicine
- Yolk Sac Tumor of the Omentum: A Case Report and Literature Review2022 | First Faculty of Medicine
- Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis2022 | First Faculty of Medicine
- Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study2022 | First Faculty of Medicine
- Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study2020 | First Faculty of Medicine
- A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX)2019 | First Faculty of Medicine
- Oncological outcome of surgical management in patients with recurrent uterine cancer-a multicenter retrospective cohort study-CEEGOG EX01 Trial2019 | First Faculty of Medicine
Loading network view...